TRY0217
methyl (2S,3R,4S)-4-{[(1R)-2-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl}-3-ethenyl-2-(beta-D-glucopyranosyloxy)-3,4-dihydro-2H-pyran-5-carboxylate;Ipecoside;AIDS031406;methyl (2S)-4-[[(1R)-2-acetyl-6,7-dihydroxy-3,4-dihydro-1H-isoquinolin-1-yl]methyl]-3-ethenyl-2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-5-carboxylate;(4S)-3-(2-methyl-2-propenoyl)-4-phenyl-2-oxazolidinone;(4S)-4-phenyl-N-methacryloyloxazolidin-2-one;(4S)-N-Methacryloyl-4-phenyl-2-oxazolidinone;(S)-3-methacryloyl-4-phenyloxazolidin-2-one;2-Oxazolidinone, 3-(2-methyl-1-oxo-2-propenyl)-4-phenyl-, (4S)-;AC1LDYI9;CTK0E7818;NSC 603972;(2S)-4α-[[(1R)-2-Acetyl-1,2,3,4-tetrahydro-6,7-dihydroxyisoquinolin-1-yl]methyl]-3α-vinyl-2β-(β-D-glucopyranosyloxy)-3,4-dihydro-2H-pyran-5-carboxylic acid methyl ester;2H-Pyran-5-carboxylic acid, 4-[(2-acetyl-1,2,3,4-tetrahydro-6,7-dihydroxy-1-isoquinolinyl)methyl]-3-ethenyl-2-(β-D-glucopyranosyloxy)-3,4-dihydro-, methyl ester, [2S-[2α,3β,4β(S*)]]-Ipecoside (6CI,8CI);Methyl (2R,3S,4R)-4-[[(1S)-2-acetyl-6,7-dihydroxy-3,4-dihydro-1H-isoquinolin-1-yl]methyl]-3-ethenyl-
C27H35NO12
565.57
